Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2013 3
2014 6
2015 7
2016 4
2017 1
2018 3
2019 6
2020 3
2021 2
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Successful haploidentical bone marrow transplantation in Griscelli syndrome type 2 with non-busulfan-based regimen and post-transplantation cyclophosphamide: a case report and review of the literature.
Yamada S, Maruyama Y, Saito S, Komori K, Morokawa H, Okura E, Hirabayashi K, Furui Y, Kurata T, Nishioka M, Fukuyama T, Sakashita K, Nakazawa Y. Yamada S, et al. Among authors: hirabayashi k. Pediatr Hematol Oncol. 2024 May;41(4):296-300. doi: 10.1080/08880018.2023.2273880. Epub 2023 Oct 31. Pediatr Hematol Oncol. 2024. PMID: 37906298 Review. No abstract available.
Erratum: Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
Chinsuwan T, Hirabayashi K, Mishima S, Hasegawa A, Tanaka M, Mochizuki H, Shimoi A, Murakami T, Yagyu S, Shimizu K, Nakazawa Y. Chinsuwan T, et al. Among authors: hirabayashi k. Mol Ther Oncolytics. 2023 Oct 11;31:100735. doi: 10.1016/j.omto.2023.100735. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 37860015 Free PMC article.
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.
Chinsuwan T, Hirabayashi K, Mishima S, Hasegawa A, Tanaka M, Mochizuki H, Shimoi A, Murakami T, Yagyu S, Shimizu K, Nakazawa Y. Chinsuwan T, et al. Among authors: hirabayashi k. Mol Ther Oncolytics. 2023 Sep 16;31:100728. doi: 10.1016/j.omto.2023.100728. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 37822488 Free PMC article.
Intraoperative Placement of an Absorbable Spacer Prior to Radiation Therapy for a Malignant Peripheral Nerve Sheath Tumor.
Endo Y, Fukuzawa T, Irie M, Sasaki H, Kudo H, Ando R, Okubo R, Katayama S, Hashimoto M, Sato K, Tachibana M, Aoki H, Araya M, Hirabayashi K, Saito S, Masaki H, Nakazawa Y, Sasahara Y, Wada M. Endo Y, et al. Among authors: hirabayashi k. Case Rep Oncol. 2022 May 20;15(2):541-546. doi: 10.1159/000524824. eCollection 2022 May-Aug. Case Rep Oncol. 2022. PMID: 35813702 Free PMC article.
41 results